AFP and breast cancer: Comparatively, patients with MPM-BC ≤ 0.45 and AFP ≤ 20 ng/mL exhibited the survival rate of 69.63%, whereas, patients with MPM-BC > 0.45 and AFP > 20 ng/mL had a low survival rate of 5.64% (Figure 6D).